Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...

Analysts are intrested in these 5 stocks: ( ($VZLA) ), ( ($COTY) ), ( ($KLRS) ), ( ($ANNX) ) and ( ($BRO) ). Here is a breakdown of their recent ...

Electricity has always been central to how life works, from the firing of neurons to the beating of the heart, but new ...

Miracle Hill Thrift Store isn’t just a shopping destination—it’s a financial revolution disguised as rows of gently-used ...

For South Carolina residents, Miracle Hill isn’t just a store – it’s a community institution, a budget-stretcher, and a ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

There are "costs of life" that mechanical physics cannot calculate. A clear example is the energy required to keep specific ...

Omeros Corporation (NASDAQ: OMER) today announced a revised date for its conference call to discuss the recent FDA approval ...

Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...